LUNG May 2024 7.500 call
| Previous close | 2.3500 |
| Open | 2.3500 |
| Bid | 0.0000 |
| Ask | 2.6500 |
| Strike | 7.50 |
| Expiry date | 2024-05-17 |
| Day's range | 2.3500 - 2.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
GlobeNewswirePulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that the Compensation Committee of the Board of Directors of Pulmonx (the “Compensation Committee”) granted inducement awards consisting of a non-statutory stock option to purchase 241,409 shares of common stock and a time-based restricted stock unit award for 125,870 shares of common stock on Ma
ZacksWall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?
The consensus price target hints at a 56.1% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Simply Wall St.Earnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Pulmonx Corporation ( NASDAQ:LUNG ) investors will be delighted, with the company turning in some strong numbers with...
